We refer to our announcements dated 7 October 2020 and 6 July 2021 in regards to the Memorandum of Understanding (“MOU”) entered into between the Company and Dato’ Dr. Suhaini Bin Kadiman (NRIC No. 690530-01-5287) (“DS”) for the proposed provision of medical advisory and clinical research consultation and services by DS.

The Board of Directors of BKCB wishes to announce that as of todate, the MOU on the above matter remain status quo and any further development thereon shall be announced in due course.

This announcement is dated 6 October 2021.